[HTML][HTML] Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

T Okusaka, J Furuse - Journal of Gastroenterology, 2020 - Springer
The prognosis of patients with pancreatic cancer continues to remain dismal, even though
numerous trials have been conducted to establish more effective therapies in Japan and …

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

T Okusaka, J Furuse - Journal of Gastroenterology, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The prognosis of patients with pancreatic
cancer continues to remain dismal, even though numerous trials have been conducted to …

[HTML][HTML] Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

T Okusaka, J Furuse - Journal of Gastroenterology, 2020 - ncbi.nlm.nih.gov
The prognosis of patients with pancreatic cancer continues to remain dismal, even though
numerous trials have been conducted to establish more effective therapies in Japan and …

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

O Takuji, F Junji - Journal of Gastroenterology, 2020 - search.proquest.com
The prognosis of patients with pancreatic cancer continues to remain dismal, even though
numerous trials have been conducted to establish more effective therapies in Japan and …

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines.

T Okusaka, J Furuse - Journal of Gastroenterology, 2020 - europepmc.org
The prognosis of patients with pancreatic cancer continues to remain dismal, even though
numerous trials have been conducted to establish more effective therapies in Japan and …

Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines

T Okusaka, J Furuse - Journal of gastroenterology, 2020 - pubmed.ncbi.nlm.nih.gov
The prognosis of patients with pancreatic cancer continues to remain dismal, even though
numerous trials have been conducted to establish more effective therapies in Japan and …